These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunotherapy of sepsis. van der Poll T Lancet Infect Dis; 2001 Oct; 1(3):165-74. PubMed ID: 11871493 [TBL] [Abstract][Full Text] [Related]
4. The potential of alkaline phosphatase as a treatment for sepsis-associated acute kidney injury. Peters E; Masereeuw R; Pickkers P Nephron Clin Pract; 2014; 127(1-4):144-8. PubMed ID: 25343839 [TBL] [Abstract][Full Text] [Related]
5. Novel potential therapies for septic shock. Azevedo LC; Park M; Schettino GP Shock; 2008 Oct; 30 Suppl 1():60-6. PubMed ID: 18704007 [TBL] [Abstract][Full Text] [Related]
6. Possible interventional therapies in severe sepsis or septic shock. Wu CC Acta Anaesthesiol Taiwan; 2012 Jun; 50(2):74-7. PubMed ID: 22769862 [TBL] [Abstract][Full Text] [Related]
7. Emerging drugs for the treatment of sepsis. Heming N; Lamothe L; Ambrosi X; Annane D Expert Opin Emerg Drugs; 2016; 21(1):27-37. PubMed ID: 26751198 [TBL] [Abstract][Full Text] [Related]
8. Sepsis immunopathology: perspectives of monitoring and modulation of the immune disturbances. Skirecki T; Borkowska-Zielińska U; Złotorowicz M; Hoser G Arch Immunol Ther Exp (Warsz); 2012 Apr; 60(2):123-35. PubMed ID: 22301668 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of four immunomodulatory therapies for relapsing-remitting multiple sclerosis: a Markov model based on long-term clinical data. Bell C; Graham J; Earnshaw S; Oleen-Burkey M; Castelli-Haley J; Johnson K J Manag Care Pharm; 2007 Apr; 13(3):245-61. PubMed ID: 17407391 [TBL] [Abstract][Full Text] [Related]
10. Alkaline phosphatase as a treatment of sepsis-associated acute kidney injury. Peters E; van Elsas A; Heemskerk S; Jonk L; van der Hoeven J; Arend J; Masereeuw R; Pickkers P J Pharmacol Exp Ther; 2013 Jan; 344(1):2-7. PubMed ID: 23131595 [TBL] [Abstract][Full Text] [Related]
11. [Rationale for the use of extracorporeal treatments for sepsis]. Ronco C; D'Intini V; Bellomo R; Ricci Z; Bonello M; Ratanarat R; Salvatori G; Bordoni V; Andricos E; Brendolan A Anesteziol Reanimatol; 2005; (2):87-91. PubMed ID: 15938108 [TBL] [Abstract][Full Text] [Related]
12. Septic shock: new pharmacotherapy options or better trial design? Vincent JL; Van Nuffelen M Expert Opin Pharmacother; 2013 Apr; 14(5):561-70. PubMed ID: 23452102 [TBL] [Abstract][Full Text] [Related]
15. When and how should sepsis patients be fed? Elke G; Kott M; Weiler N Curr Opin Clin Nutr Metab Care; 2015 Mar; 18(2):169-78. PubMed ID: 25635596 [TBL] [Abstract][Full Text] [Related]
16. The role of high mobility group box-1 protein in severe sepsis. Sunden-Cullberg J; Norrby-Teglund A; Treutiger CJ Curr Opin Infect Dis; 2006 Jun; 19(3):231-6. PubMed ID: 16645483 [TBL] [Abstract][Full Text] [Related]
17. Evaluation and management of abdominal sepsis. Sartelli M Curr Opin Crit Care; 2020 Apr; 26(2):205-211. PubMed ID: 32004193 [TBL] [Abstract][Full Text] [Related]
18. Thrombomodulin in sepsis. Levi M; Van Der Poll T Minerva Anestesiol; 2013 Mar; 79(3):294-8. PubMed ID: 23241735 [TBL] [Abstract][Full Text] [Related]